Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
enVVeno Medical Corporation
NVNO | US
12.95
USD0.35
2.78%
NVNO | US
Loading StockChartView...
About enVVeno Medical Corporation
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
23/04/2026
Close
12.95
Open
12.80
High
13.00
Low
12.50
enVVeno Medical Corporation a clinical med-tech company focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine California.
View LessNVNO | US
Risk
43.5
Sharpe
-0.75
Luna's Score
51/100
Recommendation
Hold
Luna says (NVNO | US)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
38.5%1 month
43.5%3 months
95.7%6 months
105.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.52
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-0.87
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-22.37M
MarketCap
227.09M
MarketCap(USD)
227.09M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-61.28
Short ratio
4.16
Short perc.
4.36
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.27
Range1M
3.21
Range3M
4.33
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.72
Price X volume
177.26K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.87 | 46.09 | Cheaper |
| Ent. to Revenue | - | 14.34 | - |
| PE Ratio | - | 30.41 | - |
| Price to Book | 1.52 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 95.74 | 64.12 | Riskier |
| Debt to Equity | 0.03 | -145.53 | Expensive |
| Debt to Assets | 0.03 | 0.35 | Cheaper |
| Market Cap | 227.09M | 9.70B | Emerging |
